Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Metastatic Neuroendocrine Prostate Cancer 1 Advanced Solid Tumors 1

Interventions

pembrolizumab 2 tislelizumab 1 sacituzumab govitecan 1 fludarabine 1 SYS6006 COVID-19 vaccine 1 Pemetrexed 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Drug Therapy 1 Cetuximab 1 Carboplatin 1 Antiemetics 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Antiemetics × 30 days × Clear all

NCT06242691 2026-06-05

MK-1200-002

Merck Sharp & Dohme LLC

Phase 1/2 Completed

13 enrolled 21 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡